Edition:
United Kingdom

Sanofi India Ltd (SANO.NS)

SANO.NS on National Stock Exchange of India

4,665.15INR
9:59am GMT
Change (% chg)

Rs18.45 (+0.40%)
Prev Close
Rs4,646.70
Open
Rs4,639.50
Day's High
Rs4,699.00
Day's Low
Rs4,566.30
Volume
10,114
Avg. Vol
8,312
52-wk High
Rs4,950.00
52-wk Low
Rs3,940.00

Chart for

About

Sanofi India Limited is an India-based company, which is engaged in the manufacture and sale of pharmaceutical products. The Company provides medicines for the treatment of patients in various therapeutic areas, including cardiology, thrombosis, oncology, diabetes, central nervous system, internal medicine and consumer... (more)

Overall

Beta: 0.13
Market Cap(Mil.): Rs93,862.45
Shares Outstanding(Mil.): 23.03
Dividend: 18.00
Yield (%): 1.67

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Sanofi India Sept-qtr profit up 40 pct

* Sept quarter total revenue from operations 6.68 billion rupees

31 Oct 2017

BRIEF-Sanofi India launches Combiflam ICYHOT pain relief topical in India

* Says Sanofi launches Combiflam ICYHOT pain relief topical in India Source text for Eikon: Further company coverage:

11 Sep 2017

BRIEF-Sanofi India seeks members' nod for increasing loan to 4.45 bln rupees to Shantha Biotechnics

* Seeks members' nod for increasing loan from INR 3.30 billion to INR 4.45 billion to Shantha Biotechnics Pvt Ltd Source text - http://bit.ly/2vHzQqW Further company coverage:

26 Jul 2017

BRIEF-Sanofi India declares interim dividend of 18 rupees per share

* Says declared an interim dividend of INR 18 per equity share Source text - (http://bit.ly/2viW1nc) Further company coverage:

19 Jul 2017

BRIEF-Sanofi India June-qtr profit down 14.4 pct

* June quarter total revenue from operations 6.01 billion rupees

19 Jul 2017

Earnings vs. Estimates